Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma.

    Velazquez EF, Yancovitz M, Pavlick A, Berman R, Shapiro R, Bogunovic D, O'Neill D, Yu YL, Spira J, Christos PJ, Zhou XK, Mazumdar M, Nanus DM, Liebes L, Bhardwaj N, Polsky D, Osman I.

    J Transl Med. 2007 Jan 5;5:2.PMID: 17207277 [PubMed - in process]Related articlesFree article

    2.

    Expression of neutral endopeptidase (NEP/CD10) on pancreatic tumor cell lines, pancreatitis and pancreatic tumor tissues.

    Erhuma M, Köbel M, Mustafa T, Wulfänger J, Dralle H, Hoang-Vu C, Langner J, Seliger B, Kehlen A.

    Int J Cancer. 2007 Jun 1;120(11):2393-400.PMID: 17294442 [PubMed - indexed for MEDLINE]Related articles

    3.

    The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.

    Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, Shevde LA, Li W, Eschrich S, Daud A, Ju J, Matta J.

    BMC Med Genomics. 2008 Apr 28;1:13.PMID: 18442402 [PubMed]Related articlesFree article

    4.

    Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression.

    Osman I, Dai J, Mikhail M, Navarro D, Taneja SS, Lee P, Christos P, Shen R, Nanus DM.

    Cancer. 2006 Dec 1;107(11):2628-36.PMID: 17083125 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines.

    Usmani BA, Harden B, Maitland NJ, Turner AJ.

    Clin Sci (Lond). 2002 Aug;103 Suppl 48:314S-317S.PMID: 12193112 [PubMed - indexed for MEDLINE]Related articles

    6.

    Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers.

    Bertucci F, Pages C, Finetti P, Rochaix P, Lamant L, Devilard E, Nguyen C, Houlgatte R, Birnbaum D, Xerri L, Brousset P.

    Anticancer Res. 2007 Sep-Oct;27(5A):3441-9.PMID: 17970093 [PubMed - indexed for MEDLINE]Related articles

    7.

    Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling.

    Sumitomo M, Shen R, Walburg M, Dai J, Geng Y, Navarro D, Boileau G, Papandreou CN, Giancotti FG, Knudsen B, Nanus DM.

    J Clin Invest. 2000 Dec;106(11):1399-407.PMID: 11104793 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.

    Cohen AJ, Bunn PA, Franklin W, Magill-Solc C, Hartmann C, Helfrich B, Gilman L, Folkvord J, Helm K, Miller YE.

    Cancer Res. 1996 Feb 15;56(4):831-9.PMID: 8631021 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.
    10.

    Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.

    Song J, Aumüller G, Xiao F, Wilhelm B, Albrecht M.

    Prostate. 2004 Mar 1;58(4):394-405.PMID: 14968440 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Expression of neutral endopeptidase and motility-related protein-1 in cutaneous malignant melanoma]

    Wu Y, Zhang XB, Liu HJ, Zheng LD, Li JW, Lin Y.

    Zhonghua Bing Li Xue Za Zhi. 2007 Jul;36(7):466-9. Chinese. PMID: 17845760 [PubMed - in process]Related articles

    13.

    The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells.

    Slipicevic A, Jørgensen K, Skrede M, Rosnes AK, Trøen G, Davidson B, Flørenes VA.

    BMC Cancer. 2008 Sep 30;8:276.PMID: 18826602 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Neutral endopeptidase protein expression and prognosis in localized prostate cancer.

    Osman I, Yee H, Taneja SS, Levinson B, Zeleniuch-Jacquotte A, Chang C, Nobert C, Nanus DM.

    Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4096-100.PMID: 15217945 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Comparative levels of CALLA/neutral endopeptidase on normal granulocytes, leukemic cells, and transfected COS-1 cells.

    Tran-Paterson R, Boileau G, Giguère V, Letarte M.

    Blood. 1990 Aug 15;76(4):775-82.PMID: 2166607 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Neutral endopeptidase 24.11/CD10 suppresses progressive potential in ovarian carcinoma in vitro and in vivo.

    Kajiyama H, Shibata K, Terauchi M, Morita T, Ino K, Mizutani S, Kikkawa F.

    Clin Cancer Res. 2005 Mar 1;11(5):1798-808.PMID: 15756002 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.

    Demunter A, Libbrecht L, Degreef H, De Wolf-Peeters C, van den Oord JJ.

    Mod Pathol. 2002 Apr;15(4):454-61.PMID: 11950921 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    CD10/neutral endopeptidase 24.11 in developing human fetal lung. Patterns of expression and modulation of peptide-mediated proliferation.

    Sunday ME, Hua J, Torday JS, Reyes B, Shipp MA.

    J Clin Invest. 1992 Dec;90(6):2517-25.PMID: 1469102 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The expression and localization of neutral endopeptidase 24.11/CD10 in human gestational trophoblastic diseases.

    Ino K, Suzuki T, Uehara C, Nagasaka T, Okamoto T, Kikkawa F, Mizutani S.

    Lab Invest. 2000 Nov;80(11):1729-38.PMID: 11092533 [PubMed - indexed for MEDLINE]Related articles

    20.

    Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.

    Kitago M, Martinez SR, Nakamura T, Sim MS, Hoon DS.

    Clin Cancer Res. 2009 May 1;15(9):2988-94. Epub 2009 Mar 31.PMID: 19336521 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data